Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
AFFIRMA BIOTECH SL logo — Affirma Biotech develops new products to overcome the challe...

AFFIRMA BIOTECH SL

Affirma Biotech develops new products to overcome the challenge of Multi Drug Resistant and Chronic Infections

Founded 2020 Spain Spain 5 employees Series Unknown Total: $1.98M Biopharma, Biotechnology +2

General Information

Company Name AFFIRMA BIOTECH SL
Founded Year 2020
Location Spain Spain +1
Employees 5
Industries Biopharma, Biotechnology, Life Sciences +1
Funding Stage Series Unknown
Social

Get notified when AFFIRMA BIOTECH SL moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About AFFIRMA BIOTECH SL

AFFIRMA BIOTECH SL

Slogan: Affirma Biotech develops new products to overcome the challenge of Multi Drug Resistant and Chronic Infections

Description: Affirma Biotech is a start-up company specialized in the discovery and development of new anti-infective drugs via immunomodulation.

Founded: 2020

Industries: Biopharma, Biotechnology, Pharmaceutical

Headquarter: Spain

Last Investment: €1.73M Venture Round investment at 01 February 2024

Last Investment Investors: Nara Capital, SeedBlink, Reig Jofre, GENESIS Biomed, Alfons Hidalgo, Capital Cell, BCN PEPTIDES

Overall, Affirma Biotech, founded in 2020 and headquartered in Spain, is focused on developing new anti-infective drugs to address Multi Drug Resistant and Chronic Infections. The company recently secured a venture round investment of €1.73M from a group of notable investors including Nara Capital, SeedBlink, Reig Jofre, GENESIS Biomed, Alfons Hidalgo, Capital Cell, and BCN PEPTIDES. With its specialization in immunomodulation, Affirma Biotech holds promise in bringing innovative solutions to the field of biopharma, biotechnology, and pharmaceuticals.

Taxonomy: Drug development, Anti-infective drugs, Immunomodulation, Host-directed therapy, Host cell factors, Pathogen, Infectious diseases, Chronic infections, Multi Drug Resistant, Start-up company, Research and development, Pharmaceuticals, Biomedical innovation, Healthcare advancements

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Grant •••••• 1 •••• •••• 01 Feb 2024
Venture Round •••••• 7
Investor Investor Investor
•••• •••• 		01 Feb 2024

AFFIRMA BIOTECH SL Alternatives & Competitors

AFFIRMA BIOTECH SL vs
Meletios Therapeutics
Meletios Therapeutics France

Fulfil the urgent, large and unmet medical need for antiviral molecules.

Private Equity
8 employees
Biotechnology, Health and Wellness
AFFIRMA BIOTECH SL vs
ORYN THERAPEUTICS, Inc.
ORYN THERAPEUTICS, Inc. United States

Oryn Therapeutics is a clinical-stage company developing a new class of drug candidates, Orynotides.

7 employees
Biotechnology, Health Care
AFFIRMA BIOTECH SL vs
Xenikos B.V.
Xenikos B.V. The Netherlands

Developing new, innovative immunotherapy medicines that reset the immune system

Grant
1 employees
Biotechnology, Health and Wellness

FAQ About AFFIRMA BIOTECH SL

Affirma Biotech develops new products to overcome the challenge of Multi Drug Resistant and Chronic Infections
AFFIRMA BIOTECH SL was founded in 2020.
AFFIRMA BIOTECH SL is headquartered in Spain.
AFFIRMA BIOTECH SL operates in the following industries: Biopharma, Biotechnology, Life Sciences, Pharmaceutical.
AFFIRMA BIOTECH SL has approximately 5 employees.
AFFIRMA BIOTECH SL has completed 2 funding rounds, raising a total of $1.98M. The latest funding stage is Series Unknown.
Top alternatives and competitors to AFFIRMA BIOTECH SL include Meletios Therapeutics, ORYN THERAPEUTICS, Inc., Xenikos B.V., Hosthub, Enlivex Therapeutics (Nasdaq: ENLV). These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
AFFIRMA BIOTECH SL and Meletios Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors AFFIRMA BIOTECH SL and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy